Biodesix (BDSX) Non Operating Income (2019 - 2026)

Biodesix (BDSX) has reported Non Operating Income for 8 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.

• Non Operating Income for Q1 2026 came in at -$1.6 million, down 1724.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.0 million (up 31.93% YoY), and the FY2025 annual result was -$7.4 million, up 12.34% from the prior year.
• Non Operating Income was -$1.6 million for Q1 2026 at Biodesix, up from -$2.0 million in the prior quarter.
• Over five years, Non Operating Income peaked at $98000.0 in Q1 2025 and troughed at -$10.8 million in Q4 2023.
• Average Non Operating Income over 5 years is -$3.0 million, with a median of -$2.0 million recorded in 2025.
• Year-over-year, Non Operating Income plunged 83450.0% in 2024 and surged 103.78% in 2025.
• Over 5 years, Non Operating Income stood at -$6.4 million in 2022, then tumbled by 67.62% to -$10.8 million in 2023, then gained by 22.69% to -$8.4 million in 2024, then surged by 75.91% to -$2.0 million in 2025, then gained by 20.91% to -$1.6 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$1.6 million in Q1 2026, -$2.0 million in Q4 2025, and -$1.7 million in Q3 2025.